SCHEMBL1315768

SCHEMBL1315768

COc1cc(C(=O)O)c(N)cc1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.49
ALDH1A1 P00352 4/20 0.49
HPGD P15428 2/20 0.49
IDO1 P14902 1/20 0.49
HTT P42858 3/20 0.48
LMNA P02545 1/20 0.48
MAPT P10636 1/20 0.48
PGR P06401 1/20 0.44
DHODH Q02127 1/20 0.44
PDE10A Q9Y233 1/20 0.44
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
APAF1 O14727 1/20 0.43
RECQL P46063 1/20 0.43
CASP6 P55212 1/20 0.43
CACNA1B Q00975 1/20 0.43
APBA1 Q02410 1/20 0.43
MCL1 Q07820 1/20 0.43
CASP8 Q14790 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6808543 0.94 KDM4E (0.49) KDM4EALDH1A1HPGDIDO1HTT
SCHEMBL1318324 0.88 KDM4E (0.64) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL3827653 0.83 RECQL (0.54) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL19834753 0.82 ALDH1A1 (0.62) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL21857446 0.82 KDM4E (0.64) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL7649916 0.81 PGR (0.49) KDM4EALDH1A1IDO1MAPTPGR
SCHEMBL13601880 0.81 KDM4E (0.49) KDM4EALDH1A1HPGDHTTLMNA
SCHEMBL85946 0.79 KDM4E (0.69) KDM4EALDH1A1HPGDIDO1HTT
SCHEMBL25125820 0.79 ALDH1A1 (0.54) KDM4EALDH1A1HPGDMAPTLCK
SCHEMBL21836783 0.79 LCK (0.67) KDM4EALDH1A1HPGDHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
EP-2385036-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF Toyama Chemical Co., Ltd. (JP) 2011-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 KDM4E 1141/4885ALDH1A1 813/4885HPGD 1236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.